A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Re-evaluating the evidence for fecal microbiota transplantation "super-donors" in inflammatory bowel disease
[article]
2019
medRxiv
pre-print
Fecal microbiota transplantation (FMT) is a recommended treatment for recurrent Clostridioides difficile infection, and there is promise that FMT may be effective for conditions like inflammatory bowel disease (IBD). Previous FMT clinical trials have considered the possibility of a "donor effect", that is, that FMT material from different donors has different clinical efficacies. Here we lay out rigorous statistical methodology for detecting donor effects, finding that reliable detection of a
doi:10.1101/19011635
fatcat:iku2teb7hnb57cdv7itdtmq64m